The Impact of Sonifilan on the Quality of Life in Patients With Cervical Cancer
Phase of Trial: Phase I
Latest Information Update: 02 Jun 2017
Price : $35 *
At a glance
- Drugs Sizofiran (Primary) ; Antineoplastics
- Indications Adenocarcinoma; Cervical cancer; Squamous cell cancer
- Focus Therapeutic Use
- 27 May 2017 Planned End Date changed from 1 May 2016 to 1 Dec 2025.
- 27 May 2017 Planned primary completion date changed from 1 May 2014 to 1 Dec 2025.
- 04 Sep 2013 New trial record